mass. movers

Alnylam, Monsanto team up

Monsanto seed was used at this Illinois cornfield.

Bloomberg News

Monsanto seed was used at this Illinois cornfield.


Monsanto Co. and Alnylam Pharmaceuticals Inc. have formed an alliance to advance biological technologies for agricultural use. Monsanto will pay $29.2 million upfront to Alnylam, a Cambridge company that aims to develop drugs with its RNAi gene-silencing technology. It has no products on the market yet. Monsanto gets exclusive rights to use Alnylam’s technology and intellectual property in agriculture. Biologicals complement or replace chemical products in agriculture and represent a growing segment of a $1.7 billion annual market, Alnylam said. Alnylam is eligible to receive milestone payments, additional funding, and royalty payments over 10 years.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of